Einschätzungen zur Therapie der moderaten bis schweren atopischen Dermatitis mit Januskinaseinhibitoren
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Einschätzungen zur Therapie der moderaten bis schweren atopischen Dermatitis mit Januskinaseinhibitoren
Authors
Keywords
-
Journal
HAUTARZT
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-05-24
DOI
10.1007/s00105-022-05004-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Treatment of Atopic Dermatitis with Baricitinib: First Real-life Experience
- (2022) Danielle Rogner et al. ACTA DERMATO-VENEREOLOGICA
- Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis
- (2021) Thomas Bieber et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and efficacy of upadacitinib in combination with topical corticosteroids in adolescents and adults with moderate-to-severe atopic dermatitis (AD Up): results from a randomised, double-blind, placebo-controlled, phase 3 trial
- (2021) Kristian Reich et al. LANCET
- Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis
- (2021) Andrew Blauvelt et al. JAMA Dermatology
- Implementation of dupilumab in routine care of atopic eczema. Results from the German national registry TREATgermany
- (2020) S. Abraham et al. BRITISH JOURNAL OF DERMATOLOGY
- Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
- (2020) Eric L Simpson et al. LANCET
- Atopic dermatitis
- (2020) Sinéad M Langan et al. LANCET
- Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis
- (2020) Kristian Reich et al. JAMA Dermatology
- Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials
- (2020) K. Reich et al. JOURNAL OF DERMATOLOGICAL TREATMENT
- Pharmakologie der Januskinaseinhibitoren
- (2019) F. Solimani et al. HAUTARZT
- The human skin microbiome
- (2018) Allyson L. Byrd et al. NATURE REVIEWS MICROBIOLOGY
- Cutaneous Barriers and Skin Immunity: Differentiating A Connected Network
- (2018) Stefanie Eyerich et al. TRENDS IN IMMUNOLOGY
- Efficacy and safety of ruxolitinib in the treatment of patients with myelofibrosis
- (2015) Cecilia Arana Yi et al. Future Oncology
- The Multi-Modal Immune Pathogenesis of Atopic Eczema
- (2015) Kilian Eyerich et al. TRENDS IN IMMUNOLOGY
- Tofacitinib versus Methotrexate in Rheumatoid Arthritis
- (2014) Eun Bong Lee et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nonpathogenic Bacteria Alleviating Atopic Dermatitis Inflammation Induce IL-10-Producing Dendritic Cells and Regulatory Tr1 Cells
- (2013) Thomas Volz et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now